Companies: 10,795·Total market cap: $144.5T
Amedisys, Inc.

Amedisys, Inc.

AMEDNASDAQHealthcare
$100.99
+$0.01(+0.01%)
Market Cap$3.3B
P/E Ratio
52W High$101.02
52W Low$82.15

Amedisys, Inc. (AMED) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · AMED · as of Jun 8, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

2

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Amedisys, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

AMED insider buying and selling by quarter

AMED insider selling · AMED insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
884K442K0
2024 Q4
2025 Q1
2025 Q2
2025 Q3

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · AMED ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

AMED executive sell shares · AMED board member insider trading · AMED insider trading SEC filing

Showing 60 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Coye Molly Joel

Director

Other

Date

Aug 14

Shares

8,818

Price

$0.00

Value

$9

View Form 4 on SEC.gov

Klapstein Julie D

Director

Other

Date

Aug 14

Shares

16,031

Price

$0.00

Value

$16

View Form 4 on SEC.gov

Kusserow Paul B. K.

Director

Other

Date

Aug 14

Shares

621

Price

Value

View Form 4 on SEC.gov

Kusserow Paul B. K.

Director

Other

Date

Aug 14

Shares

439,124

Price

$0.00

Value

$439

View Form 4 on SEC.gov

Rideout Jeffrey A

Director

Other

Date

Aug 14

Shares

9,335

Price

$0.00

Value

$9

View Form 4 on SEC.gov

Muscato Nick

Chief Strategy Officer

Other

Date

Aug 14

Shares

3,067

Price

$0.00

Value

$3

View Form 4 on SEC.gov

Muscato Nick

Chief Strategy Officer

Option

Date

Aug 14

Shares

3,468

Price

Value

View Form 4 on SEC.gov

Muscato Nick

Chief Strategy Officer

Other

Date

Aug 14

Shares

212

Price

Value

View Form 4 on SEC.gov

Kline Teresa L.

Director

Other

Date

Aug 14

Shares

9,818

Price

$0.00

Value

$10

View Form 4 on SEC.gov

CAPPS VICKIE L

Director

Other

Date

Aug 14

Shares

9,818

Price

$0.00

Value

$10

View Form 4 on SEC.gov

Griffin Jennifer G

Chief Legal Officer

Other

Date

Aug 14

Shares

10,700

Price

$0.00

Value

$11

View Form 4 on SEC.gov

Griffin Jennifer G

Chief Legal Officer

Other

Date

Aug 14

Shares

341

Price

Value

View Form 4 on SEC.gov

Ginn Scott G

EVP, CFO & COO

Other

Date

Aug 14

Shares

31,211

Price

$0.00

Value

$31

View Form 4 on SEC.gov

Ginn Scott G

EVP, CFO & COO

Option

Date

Aug 14

Shares

10,399

Price

Value

View Form 4 on SEC.gov

Ginn Scott G

EVP, CFO & COO

Other

Date

Aug 14

Shares

2,714

Price

Value

View Form 4 on SEC.gov

Bohnert Denise M.

Chief Compliance Officer

Other

Date

Aug 14

Shares

9,283

Price

$0.00

Value

$9

View Form 4 on SEC.gov

Bohnert Denise M.

Chief Compliance Officer

Option

Date

Aug 14

Shares

3,468

Price

Value

View Form 4 on SEC.gov

Bohnert Denise M.

Chief Compliance Officer

Other

Date

Aug 14

Shares

214

Price

Value

View Form 4 on SEC.gov

Guidroz Allyson

CAO

Other

Date

Aug 14

Shares

898

Price

$0.00

Value

$1

View Form 4 on SEC.gov

Guidroz Allyson

CAO

Other

Date

Aug 14

Shares

1.5

Price

Value

View Form 4 on SEC.gov

Ashworth Richard M

President and CEO · Director

Other

Date

Aug 14

Shares

45,870

Price

$0.00

Value

$46

View Form 4 on SEC.gov

Ashworth Richard M

President and CEO · Director

Option

Date

Aug 14

Shares

62,641

Price

Value

View Form 4 on SEC.gov

Ashworth Richard M

President and CEO · Director

Option

Date

Aug 14

Shares

39,850

Price

Value

View Form 4 on SEC.gov

Ashworth Richard M

President and CEO · Director

Other

Date

Aug 14

Shares

39,850

Price

Value

View Form 4 on SEC.gov

Samuels Ivanetta Davis

Director

Other

Date

Aug 14

Shares

7,600

Price

$0.00

Value

$8

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About AMED insider trading

AMED insider trades

Amedisys, Inc. (AMED) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Guidroz Allyson (CAO), Muscato Nick (Chief Strategy Officer), Ginn Scott G (EVP, CFO & COO). Over the past 12 months, 5 insiders have filed transactions with the SEC. AMED insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Amedisys, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

AMED insider trading · 5 questions

The insiders of Amedisys, Inc. (AMED) include executives and directors such as Guidroz Allyson (CAO), Muscato Nick (Chief Strategy Officer), Ginn Scott G (EVP, CFO & COO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

AMED board member insider tradingwho are AMED insidersAMED insider rosterAmedisys, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026